MD vs CON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 18, 2026

MD

52.4
AI Score
VS
MD Wins

CON

38.0
AI Score

Investment Advisor Scores

MD

52score
Recommendation
HOLD

CON

38score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric MD CON Winner
Forward P/E 9.2937 18.018 MD
PEG Ratio 0.2433 0 Tie
Revenue Growth 4.0% 10.0% CON
Earnings Growth 6.5% 47.0% CON
Tradestie Score 52.4/100 38.0/100 MD
Profit Margin 9.0% 8.7% MD
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

MD 1M: +14.3% · 3M: +12.5% CON 1M: +14.9% · 3M: +26.4%

Current Technical Phase

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 75

RSI (14): 74.7 · Price: $29.55

CON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.9% over 20 days), RSI 75

RSI (14): 74.8 · Price: $39.97

Fundamentals Snapshot

Metric MD CON
Market Cap — —
Forward P/E 12.1 21.7
Trailing P/E 13.4 25.2
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.2%
EPS 2.09 1.55
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, MD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.